Enteroparasitosis presents high prevalence in developing countries, and is frequent among children, and those with disabilities present even higher susceptibility. The present study evaluated 156 children with neurological disorders to whose parents or guardians an epidemiological questionnaire was applied with a view to identifying risk factors. Stool samples were processed using Ritchie modified by Young, Faust et al., Lutz and Baermann-Moraes techniques. Thirteen samples (8.3%) were positive, being Blastocystis sp. the most frequent parasite (46.2%). Higher positivity was observed for protozoa, especially non-pathogenic. A statistically significant association was only found between the educational level of the mother and positivity for enteroparasites. Among positive children, the habit of placing their hands and objects in their mouths and the consumption of raw vegetables was more frequent. The results show the existence of care and sanitation minimizing the acquisition of intestinal parasite diseases. It is important to alert parents and caregivers about personal hygiene, water and food quality, as well as the environment, considering that transmission of these parasites occurs via the fecal-oral route, in association with multiple factors.
Introduction: The Zika virus is an arbovirus of the Flaviviridae family that causes asymptomatic and symptomatic infections. The clinical diagnosis of arboviroses is difficult in areas with cocirculation of these viruses and, therefore, laboratory confirmation based on host immune response is important, especially for pregnant women. The use of recombinant proteins as antigens aims to improve the sensitivity and specificity of the immunological test. Objective: The goal of this study is the production of recombinant ZIKV envelope (ENV) protein and the standardization of an ELISA for the arbovirosis differential diagnosis. Methodology: Expression of the ZIKV partial ENV recombinant protein was performed using a synthetic DNA inserted into plasmid pET28a and expressed in Escherichia coli Rosetta strain. The selected region from ENV protein was the one that showed less homology with ENV Dengue protein. Indirect ELISA tests for IgG detection were standardized using the recENV in the concentration of 0.25 μg per well. Forty three sera from individuals living in a mountain community before Zika and Chikungunya epidemics were collected and used as controls. Reactivity threshold was calculated by the mean of the results from control sera plus two standard deviations. The ELISA conditions were: sera dilution 1:100, alkaline phosphataselinked anti-human IgG conjugate dilution of 1:5000 and after 20 minute of incubation reaction was developed using pNPP substrate and reading at 405 nm. Samples from 8 follow-up patients, ZIKV positives by real-time PCR, collected on days 1-2, 5-14 and 20-70 after medical examination were used for analysis. Results: The recombinant protein was expressed as 30 kDa and express sequence was confirmed by sequencing. In six patients tested in "homemade" IgG Zika ENV assay, the levels of IgG showed a tendency to increase with the infection time but not significantly. On the other hand, using a ZIKV IgM capture Elisa Kit from InBios (Seattle, WA 98109, EUA) in order to compare IgM and IgG levels, we found that specific IgM decreased in all follow-up samples, even the ones that still remained positive. Conclusion: These results were consistent with IgG and IgM antibodies kinetics production. Low levels of IgG in all samples could be explained by the presence in of high levels of IgM. Therefore, even as preliminary results, the use of recombinant ZIKV ENV protein showed to be useful as antigen in immunological methods for detection of antibodies against ZIKV.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.